|
ASF1A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.25749982543755E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.91689997208755E-11 |
| Normal-vs-Stage2 |
7.304500E-02 |
| Normal-vs-Stage3 |
6.375600E-03 |
| Normal-vs-Stage4 |
2.696800E-01 |
| Stage1-vs-Stage2 |
2.354000E-01 |
| Stage1-vs-Stage3 |
5.483700E-02 |
| Stage1-vs-Stage4 |
1.614000E-01 |
| Stage2-vs-Stage3 |
9.924000E-01 |
| Stage2-vs-Stage4 |
7.342400E-01 |
| Stage3-vs-Stage4 |
6.541000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.72490030539529E-10 |
| Normal-vs-AfricanAmerican |
5.39510000008292E-08 |
| Normal-vs-Asian |
5.403800E-03 |
| Caucasian-vs-AfricanAmerican |
4.686400E-01 |
| Caucasian-vs-Asian |
3.096000E-01 |
| AfricanAmerican-vs-Asian |
7.211600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.8625990466935E-11 |
| Normal-vs-Female |
2.39850000000041E-05 |
| Male-vs-Female |
3.618600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.51610000000258E-05 |
| Normal-vs-Extreme_Weight |
2.6878499426175E-12 |
| Normal-vs-Obese |
3.89760000052419E-07 |
| Normal-vs-Extreme_Obese |
3.690800E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.867800E-02 |
| Normal_Weight-vs-Obese |
9.144200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.922400E-01 |
| Extreme_Weight-vs-Obese |
2.913900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.639000E-01 |
| Obese-vs-Extreme_Obese |
6.651400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.975500E-03 |
| Normal-vs-Age(41-60Yrs) |
2.31450000054423E-07 |
| Normal-vs-Age(61-80Yrs) |
6.7506000789308E-11 |
| Normal-vs-Age(81-100Yrs) |
2.39899999865401E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.888400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.249030E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.506170E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.032200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.946170E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.860570E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.63413726994577E-12 |
| Normal-VS-Type2 PRCC |
1.2056999953991E-08 |
| Normal-VS-KIRP CIMP |
9.976600E-01 |
| Normal-VS-Unclassified PRCC |
9.626800E-04 |
| Type1 PRCC-VS-Type2 PRCC |
3.919000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.594120E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.068600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.904500E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
6.179200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.146100E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.53020000004389E-06 |
| Normal-vs-N1 |
4.032200E-01 |
| Normal-vs-N2 |
2.989400E-04 |
| N0-vs-N1 |
6.781000E-03 |
| N0-vs-N2 |
5.204600E-01 |
| N1-vs-N2 |
5.028400E-02 |
|
|
